Today: 20 May 2026
Sprott Physical Silver Trust (PSLV) slides 6% as silver tumbles — what investors watch next
1 January 2026
2 mins read

Sprott Physical Silver Trust (PSLV) slides 6% as silver tumbles — what investors watch next

NEW YORK, January 1, 2026, 06:17 ET — Market closed

  • PSLV fell 6.23% to $23.65 on Dec. 31, tracking a sharp drop in silver prices into year-end.
  • Sprott’s reported NAV was $24.59, leaving the trust at a 3.83% discount at the close.
  • Traders are focused on CME margin changes, rates and early-January U.S. data for the next move in silver-linked funds.

Shares of Sprott Physical Silver Trust (PSLV) slid 6.23% to $23.65 in the last U.S. session on Dec. 31, with more than 32 million shares changing hands. U.S. equity markets are closed on Thursday for New Year’s Day.

PSLV is a closed-end trust that holds physical silver and trades like a stock, making it a quick proxy for the metal when futures markets lurch. The latest downdraft underscored how quickly sentiment can turn after a year of outsized gains in precious metals.

Silver futures sank more than 9% to about $70.40 an ounce at 4 p.m. ET on Wednesday, after CME Group hiked margin requirements for precious metals for a second time in less than a week, Investopedia reported. The 10-year Treasury yield rose to about 4.17%, adding pressure on non-yielding assets like precious metals.

Margin is the cash traders must post to keep futures positions open; higher requirements can force leveraged players to cut risk quickly. The selloff was “largely technical,” Dilin Wu, a strategist at Pepperstone Group, said in comments carried by the Los Angeles Times. Los Angeles Times

Sprott reported a net asset value of $24.59 per unit for PSLV as of Dec. 31, versus a market close of $23.65, leaving the trust at a 3.83% discount. The trust held 210,706,099 ounces of silver with net assets of about $15.11 billion and said it stores fully allocated bars at the Royal Canadian Mint. Net asset value, or NAV, is the per-unit value of the underlying bullion; closed-end vehicles can trade away from NAV when trading demand shifts.

On the futures side, the active Comex silver contract last traded around $70.98, down about 8.9%, CME data showed.

Other silver-backed funds fell in tandem: iShares Silver Trust (SLV) dropped 6.61% to $64.42 on Dec. 31, while abrdn Physical Silver Shares ETF (SIVR) lost 6.57% to $67.64.

Despite the late-December shakeout, silver gained 161% in 2025 and briefly pushed past $80 an ounce for the first time, Reuters reported. Analysts see room for further gains in 2026 if interest rates fall, with support also tied to low inventories, supply constraints and industrial demand, Reuters said.

For PSLV holders, the extra wrinkle is the premium/discount: when selling pressure hits, the market price can slip faster than the bullion-backed NAV, widening the gap. That gap can narrow just as quickly if silver stabilises and buyers return.

Before the next session on Friday, Jan. 2, traders will watch whether silver steadies once normal liquidity returns after the holiday. Any further changes in futures margin rules, or signs that forced liquidation is fading, would also shape the tone for PSLV.

Macro data loom early in January. Weekly initial jobless claims are next due on Jan. 8, followed by the U.S. employment report for December on Jan. 9, according to the St. Louis Fed and the Labor Department’s schedule. The Federal Reserve’s next policy meeting is set for Jan. 27-28.

Stock Market Today

  • Wall Street Price Targets: Lululemon Rated Buy, Hormel and Walker & Dunlop Marked Sell for May 2026
    May 20, 2026, 4:23 AM EDT. A recent StockStory analysis highlights Wall Street price targets for May 2026, identifying one stock recommended to buy and two to sell. Lululemon (NASDAQ:LULU) is rated a buy with a projected 47.9% return, supported by strong fundamentals. Conversely, Hormel Foods (NYSE:HRL), known for SPAM, and Walker & Dunlop (NYSE:WD) face selling pressure despite upside targets of 33.2% and 29.6%, respectively. Hormel battles declining unit sales and shrinking earnings, while Walker & Dunlop suffers from falling net interest income and equity erosion. Investors should weigh these fundamentals against price target optimism before making decisions.

Latest articles

Meiwu Technology Stock Jumps Again After 97% Surge: Why WNW Is Moving Now

Meiwu Technology Stock Jumps Again After 97% Surge: Why WNW Is Moving Now

20 May 2026
New York, May 20, 2026, 04:12 EDT Meiwu Technology Company Limited shares were bid higher before the bell on Wednesday, extending a sharp rally that nearly doubled the Nasdaq-listed stock in the prior session. WNW closed Tuesday at $4.75, up 97.10%, after trading between $3.70 and $6.39 on volume of about 51.9 million shares. In premarket trade — the early-hours session before regular U.S. trading — the stock was quoted at $5.31, up 11.79%, at 4:09 a.m. EDT. The move matters now because the rally is coming just days after Meiwu disclosed fresh financing tied to a planned AI skincare
Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

20 May 2026
Astera Labs shares rose 13.3% to $244.26 on Tuesday after management outlined a faster ramp for its Scorpio X fabric switches and optical networking tied to Nvidia’s NVLink Fusion. The move followed presentations at J.P. Morgan’s tech conference and comes ahead of Nvidia’s earnings Wednesday. Astera’s first-quarter revenue jumped 93% to $308.4 million, with second-quarter guidance above analyst forecasts.
Snowflake Shares Rise Ahead of Results With AI Demand in Focus

Snowflake Shares Rise Ahead of Results With AI Demand in Focus

20 May 2026
Snowflake shares climbed 3.2% to $169.55 Tuesday after BofA Securities raised its price target to $205 and predicted strong fiscal Q1 results next week. Mizuho Securities channel checks indicated continued demand for Snowflake’s data and AI products. The company reports earnings after the market closes May 27. Recent deals include a $400 million contract and partnerships with OpenAI and Anthropic.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop